User profiles for Emilie Seydoux
 | Emilie SeydouxUniversity Hospital Bern, University of Bern, Switzerland Verified email at insel.ch Cited by 1874 |
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
…, V Rubin, H Glantz, M Neradilek, E Seydoux… - Science, 2021 - science.org
Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have
raised concerns about resistance to neutralizing antibodies elicited by previous infection or …
raised concerns about resistance to neutralizing antibodies elicited by previous infection or …
[PDF][PDF] Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation
Antibody responses develop following SARS-CoV-2 infection, but little is known about their
epitope specificities, clonality, binding affinities, epitopes, and neutralizing activity. We …
epitope specificities, clonality, binding affinities, epitopes, and neutralizing activity. We …
[HTML][HTML] Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
SARS-CoV-2 is a betacoronavirus virus responsible for the COVID-19 pandemic. Here, we
determine the X-ray crystal structure of a potent neutralizing monoclonal antibody, CV30, …
determine the X-ray crystal structure of a potent neutralizing monoclonal antibody, CV30, …
[PDF][PDF] Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects
SARS-CoV-2 is one of three coronaviruses that have crossed the animal-to-human barrier
and caused widespread disease in the past two decades. The development of a universal …
and caused widespread disease in the past two decades. The development of a universal …
Size-dependent uptake of particles by pulmonary antigen-presenting cell populations and trafficking to regional lymph nodes
The respiratory tract is an attractive target organ for novel diagnostic and therapeutic
applications with nano-sized carriers, but their immune effects and interactions with key resident …
applications with nano-sized carriers, but their immune effects and interactions with key resident …
[HTML][HTML] Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
B cells specific for the SARS-CoV-2 S envelope glycoprotein spike were isolated from a
COVID-19-infected subject using a stabilized spike-derived ectodomain (S2P) twenty-one days …
COVID-19-infected subject using a stabilized spike-derived ectodomain (S2P) twenty-one days …
[HTML][HTML] Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
MT Orr, AP Khandhar, E Seydoux, H Liang, E Gage… - npj Vaccines, 2019 - nature.com
Aluminum salts, developed almost a century ago, remain the most commonly used adjuvant
for licensed human vaccines. Compared to more recently developed vaccine adjuvants, …
for licensed human vaccines. Compared to more recently developed vaccine adjuvants, …
Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1
…, V Rubin, H Glantz, M Neradilek, E Seydoux… - MedRxiv, 2021 - medrxiv.org
The emergence of SARS-CoV-2 variants raises concerns about their resistance to neutralizing
antibodies elicited from previous infection, or from vaccination. Here we examined …
antibodies elicited from previous infection, or from vaccination. Here we examined …
Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation
E Seydoux, B Rothen-Rutishauser, IM Nita… - International journal …, 2014 - Taylor & Francis
Introduction Nanosized particles may enable therapeutic modulation of immune responses
by targeting dendritic cell (DC) networks in accessible organs such as the lung. To date, …
by targeting dendritic cell (DC) networks in accessible organs such as the lung. To date, …
[HTML][HTML] Interaction of biomedical nanoparticles with the pulmonary immune system
F Blank, K Fytianos, E Seydoux… - Journal of …, 2017 - Springer
Engineered nanoparticles (NPs) offer site-specific delivery, deposition and cellular uptake
due to their unique physicochemical properties and were shown to modulate immune …
due to their unique physicochemical properties and were shown to modulate immune …
